Michèle BEAU-FALLER

PUPH

ORCID – ResearcherID

(+33) 03 88 27 53 67

 

 

 

Liste des publications :

 

Flippot, R., Biondani, P., Auclin, E., Xiao, D., Hendriks, L., Le Rhun, E., … Besse, B. (2019). Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2019.05.007
Beau-Faller, M., Texier, M., Blons, H., Richard, N., Escande, F., Melaabi, S., … Cadranel, J. (2019). Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2). Clinical Lung Cancer, 20(3), 222–230. https://doi.org/10.1016/j.cllc.2018.12.012
Renaud, S., Guerrera, F., Seitlinger, J., Reeb, J., Voegeli, A.-C., Legrain, M., … Massard, G. (2018). KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer. Clinical Lung Cancer, 19(6), e919–e931. https://doi.org/10.1016/j.cllc.2018.08.005
Emprou, C., Le Van Quyen, P., Jégu, J., Prim, N., Weingertner, N., Guérin, E., … Beau-Faller, M. (2018). SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients. Cancer Medicine, 7(7), 3278–3291. https://doi.org/10.1002/cam4.1545
Renaud, S., Seitlinger, J., Guerrera, F., Reeb, J., Beau-Faller, M., Voegeli, A.-C., … Massard, G. (2018). Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma. Annals of Surgical Oncology, 25(4), 1069–1078. https://doi.org/10.1245/s10434-018-6347-3
Loubière, S., Drezet, A., Beau-Faller, M., Moro-Sibilot, D., Friard, S., Wislez, M., … French Cooperative Thoracic Intergroup (IFCT). (2018). Cost-effectiveness of KRAS,EGFRandALKtesting for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. The European Respiratory Journal, 51(3), 1701467. https://doi.org/10.1183/13993003.01467-2017
Renaud, S., Falcoz, P.-E., Schaëffer, M., Guenot, D., Romain, B., Olland, A., … Massard, G. (2015). Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases. British Journal of Cancer, 113(8), 1206–1215. https://doi.org/10.1038/bjc.2015.327
Weingertner, N., Meyer, N., Voegeli, A.-C., Guenot, D., Renaud, S., Massard, G., … Beau-Faller, M. (2015). Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification. Pathology, 47(4), 320–328. https://doi.org/10.1097/PAT.0000000000000269
Prim, N., Legrain, M., Guerin, E., Mennecier, B., Weingertner, N., Voegeli, A.-C., … Beau-Faller, M. (2014). Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients. European Respiratory Review: An Official Journal of the European Respiratory Society, 23(133), 390–392. https://doi.org/10.1183/09059180.00009313
Santoro, A., Vileno, B., Palacios, Ò., Peris-Díaz, M. D., Riegel, G., Gaiddon, C., … Faller, P. (2019). Reactivity of Cu(ii)-, Zn(ii)- and Fe(ii)-thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation. Metallomics: Integrated Biometal Science, 11(5), 994–1004. https://doi.org/10.1039/c9mt00061e
Brabletz, T., Spaderna, S., Kolb, J., Hlubek, F., Faller, G., Bruns, C. J., … Freund, J.-N. (2004). Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Research, 64(19), 6973–6977. https://doi.org/10.1158/0008-5472.CAN-04-1132